Search results
Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoIonis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 55.41% and 7.04%,...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript February 21, 2024 Ionis...
Ionis Pharmaceuticals Inc EVP, Chief Scientific Officer C Bennett Sells 22,613 Shares
GuruFocus.com via Yahoo Finance· 6 months agoIonis Pharmaceuticals Inc (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development,...
Earnings Preview: Ionis Pharmaceuticals (IONS) Q3 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoIonis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Released Its Yearly Results And Analysts Are Updating...
Simply Wall St. via Yahoo Finance· 4 months agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) defied analyst predictions to release its annual results,...
Shareholders Will Probably Not Have Any Issues With Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) CEO...
Simply Wall St. via Yahoo Finance· 2 weeks agoKey Insights Ionis Pharmaceuticals' Annual General Meeting to take place on 6th of June Salary of...
Ionis Pharmaceuticals (IONS) Reports Q2 Results: What Key Metrics Have to Say (Revised)
Zacks via Yahoo Finance· 10 months agoThe headline numbers for Ionis Pharmaceuticals (IONS) give insight into how the company performed in...
The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have...
Simply Wall St. via Yahoo Finance· 1 month agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) shareholders are probably feeling a little disappointed,...
EVP CLO & General Counsel Patrick O'Neil Sells 20,825 Shares of Ionis Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 6 months agoIonis Pharmaceuticals Inc (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development,...
What Kind Of Shareholders Hold The Majority In Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Shares?
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) can tell us which group is...